Loading
DNA and Nucleic Acid Chemistry · Journal article
Molecular Medicine Reports · September 8, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review surveying the translational potential of aptamers—high-affinity, high-specificity oligonucleotide ligands—for colorectal cancer diagnosis and targeted therapy. The review organizes existing research by diagnostic and therapeutic applications but does not report quantitative evidence, clinical trial results, or comparisons that would establish efficacy or clinical utility.
Narrative review. Colorectal cancer; no specific patient population studied in primary research reported..
Aptamers possess high affinity, high specificity, and programmability suitable for tumor-targeted diagnosis and treatment. Aptamers can specifically target receptors on cancer cell surfaces and inhibit receptor activity to intervene in CRC development. Current state of research is organized around two major branches: diagnostic detection and targeted therapy.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a narrative review synthesizing preclinical and early-stage research on aptamers for colorectal cancer, raising opportunities rather than reporting primary trial evidence or definitive clinical results.
As stated by the source record.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
colorectal cancer (crc) is one of the leading causes of cancer-related deaths.The high incidence rate and poor prognosis of crc pose a serious threat to public health, and impose a notable social and economic burden.Therefore, improving the accuracy of the early diagnosis and treatment of crc is of notable importance.aptamers have substantial potential for tumor-targeted diagnosis and treatment due to their unique advantages, such as high affinity, high specificity and programmability.In the diagnosis and treatment of CRC, aptamers can specifically target receptors on the surface of cancer cells and intervene in the development of crc by inhibiting receptor activity.The present study reviews the current state of research on aptamers to provide a new scientific basis and methods for diagnosing and treating crc.The relevant research achievements are organized based on the two major branches of diagnostic detection and targeted therapy to systematically assess the translational value of various crc aptamers.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.